Clinical Trial Update: Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

View source ↗

Summary

The observational study evaluating Cerebrolysin for subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: SAH (Subarachnoid Hemorrhage) | Status: COMPLETED